|
| [ На главную ] -- [ Список участников ] -- [ Правила форума ] -- [ Зарегистрироваться ] |
| On-line: |
| Клуб болельщиков "Торпедо" Владимир / / yjXtWuCtYnbW |
| Страницы: 1 |
|
| Автор | Сообщение |
|
Colton Гость |
Добавлено: 16-08-2021 10:34 |
|
What do you study? vitamin b12 forte hevert ampullen “These encouraging findings confirm prior signals ofclinical activity seen with ganetespib in breast cancer,” Iman El-Hariry, Synta’s vice president of clinical research, said inthe statement. “The favorable safety profile, clear single-agent clinical activity, and strong rationale for combinationtherapy suggest ganetespib may have broad potential utility inbreast cancer.” |
| Страницы: 1 |
|
| Клуб болельщиков "Торпедо" Владимир / / yjXtWuCtYnbW |